Cargando…
Practice-Level Variation in Molecular Testing and Use of Targeted Therapy for Patients With Non–Small Cell Lung Cancer and Colorectal Cancer
IMPORTANCE: All patients with newly diagnosed non–small cell lung cancer (NSCLC) and colorectal cancer (CRC) should receive molecular testing to identify those who can benefit from targeted therapies. However, many patients do not receive recommended testing and targeted therapies. OBJECTIVE: To com...
Autores principales: | Roberts, Thomas J., Kehl, Kenneth L., Brooks, Gabriel A., Sholl, Lynette, Wright, Alexi A., Landrum, Mary Beth, Keating, Nancy L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148196/ https://www.ncbi.nlm.nih.gov/pubmed/37115543 http://dx.doi.org/10.1001/jamanetworkopen.2023.10809 |
Ejemplares similares
-
Evaluation of Reliability and Correlations of Quality Measures in Cancer Care
por: Keating, Nancy L., et al.
Publicado: (2021) -
Use of Germline BRCA Testing in Patients With Ovarian Cancer and Commercial Insurance
por: Cham, Stephanie, et al.
Publicado: (2022) -
Opportunities for Savings in Risk Arrangements for Oncologic Care
por: Landon, Bruce E., et al.
Publicado: (2023) -
Survival Implications Associated with Variation in Mastectomy Rates for Early-Staged Breast Cancer
por: Brooks, John M., et al.
Publicado: (2012) -
Uncertainty in lung cancer stage for survival estimation via set‐valued classification
por: Bergquist, Savannah, et al.
Publicado: (2022)